Shikimic acid promotes estrogen receptor(ER)-positive breast cancer cells proliferation via activation of NF-κB signaling
Authors:
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 312, 65-71
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancerMolecular Cancer, 2014
- Breast cancer and dietary patterns: a systematic reviewNutrition Reviews, 2013
- Up-Regulation of microRNA-126 May Contribute to Pathogenesis of Ulcerative Colitis via Regulating NF-kappaB Inhibitor IκBαPLOS ONE, 2012
- Disease burden and treatment outcomes in second-line therapy of patients with estrogen receptor-positive (ER+) advanced breast cancer: A review of the literatureThe Breast, 2012
- MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loopJournal of Clinical Investigation, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude miceFood and Chemical Toxicology, 2008
- The mutagenic and cell transforming properties of shikimic acid and some of its bacterial and mammalian metabolitesToxicology Letters, 1983
- Shikimic acidFood and Cosmetics Toxicology, 1976
- Carcinogenicity of bracken and shikimic acidNature, 1974